Lumigan Eye Drops Allergan — Research Summary
Lumigan Eye Drops are Allergan’s bimatoprost-based ophthalmic formulation designed for sophisticated laboratory research into prostaglandin F analogue mechanisms. This pharmaceutical-grade research solution enables investigators to examine prostaglandin receptor binding, intraocular pressure modulation pathways, and ocular tissue responses in controlled experimental environments. Research scientists studying Stroid UK Shop value Lumigan’s consistent bimatoprost concentration for reproducible experimental protocols. The sterile formulation maintains compound stability across extended research periods, making it ideal for comprehensive mechanistic studies.
Research Applications
Laboratory investigators utilize Lumigan to study prostaglandin F receptor activation pathways and downstream signaling cascades in ocular tissue models. The bimatoprost component enables research into aqueous humor dynamics, trabecular meshwork remodeling, and ciliary muscle contractility mechanisms. Advanced studies examine how prostaglandin analogues influence extracellular matrix composition and cellular proliferation patterns in cultured ocular cells. Researchers investigating bimatoprost formulations frequently incorporate Lumigan into comparative efficacy protocols. The standardized formulation supports reproducible experimental conditions across multiple research institutions studying ocular pharmacology.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Component | Bimatoprost |
| Manufacturer | Allergan |
| Formulation | Sterile ophthalmic solution |
| CAS Number | 155206-00-1 |
| Molecular Formula | C₂₅H₃₇NO₄ |
| Molecular Weight | 415.57 g/mol |
| Storage Conditions | 2-8°C, protect from light |
Research groups studying selective modulators often compare prostaglandin mechanisms with other receptor-selective compounds. The pharmaceutical-grade quality ensures consistent experimental outcomes when investigating prostaglandin analogue activity profiles. Scientists examining bioactive peptides may incorporate Lumigan studies to understand tissue-specific receptor selectivity patterns.
Research Compliance
Lumigan Eye Drops Allergan are supplied exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional research guidelines when handling this material.
